Epidemiological study of RRT-treated ESRD in nanjing - A ten-year experience in nearly three million insurance covered population

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Han, Yu Chen ^a   Huang, Han Ming ^b   Sun, Ling ^a   Tan, Chao Ming ^b   Gao, Min ^a   Liu, Hong ^a   Tang, Ri Ning ^a   Wang, Yan Li ^a   Wang, Bei ^c   Ma, Kun Ling ^a   Liu, Bi Cheng ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b Nanjing Municipal Human Resources and Social Security Bureau   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; EMPLOYEE; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; REIMBURSEMENT; RENAL REPLACEMENT THERAPY; URBAN AREA; URBANIZATION; ADVERSE EFFECTS; INSURANCE; KIDNEY FAILURE, CHRONIC; PROCEDURES; REGISTER;

CHINA; FEMALE; HUMANS; INCIDENCE; INSURANCE COVERAGE; KIDNEY FAILURE, CHRONIC; MALE; PREVALENCE; REGISTRIES; RENAL REPLACEMENT THERAPY;

EID: 84960539566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149038     Document Type: Article

References (20)

1. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, et al. Emergence of chronic non-communicable diseases in China. Lancet 2008; 372: 1697-705. doi: 10.1016/S0140-6736(08)61366-5 PMID: 18930526
2. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010 findings from the Global Burden of Disease Study 2010. Lancet 2013, 381: 1987-2015 doi: 10.1016/S0140-6736(13)61097-1 PMID: 23746901
3. Lancet The. China's major health challenge: control of chronic diseases. Lancet 2011; 378: 457. doi: 10.1016/S0140-6736(11)61232-4 PMID: 21821170
4. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385: 1975-82. doi: 10.1016/S0140-6736(14)61601-9 PMID: 25777665
5. Nanjing Municipal Human Resources and Social Security Bureau. Compilation of documents of Urban Employee Basic Medical Insurance (2005-2010). 2010.
6. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: across-sectional survey. Lancet 2012; 379: 815-22. doi: 10.1016/S0140-6736(12)60033-6 PMID: 22386035
7. Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2012). TherApher Dial 2014; 18: 535-602. doi: 10.1111/1744-9987.12281 PMID: 25523509
8. Steenkamp R, Rao A, Roderick P. UK Renal Registry 17th Annual Report: Chapter5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2013: National and Centre-specific Analyses. Nephron 2015; 129 Suppl 1: 99-129. doi: 10.1159/000370275 PMID: 25695809
9. U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.
10. Wu MS, Wu IW, Hsu KH. Survival Analysis of Taiwan Renal Registry Data System (TWRDS) 2000-2009. Acta Nephrologica 2012; 26: 104-108.
11. Kimmel PL, Fwu CW, Eggers PW. Segregation, Income Disparities, and Survival in Hemodialysis Patients. J Am Soc Nephrol 2013; 24: 293-301. doi: 10.1681/ASN.2012070659 PMID: 23334394
12. Kurella-Tamura M, Goldstein BA, Hall YN, Mitani AA, Winkelmayer WC. State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol 2014, 25: 1321-1329. doi: 10.1681/ASN.2013060658 PMID: 24652791
13. Dialysis Transplantation Registration Working Group of Chinese Society of Nephrology. 1999 National dialysis and transplantation registration. Chinese J Nephro 2001; 17: 77-78.
14. Zuo L, Wang M, Chinese Association of Blood Purification Management of Chinese Hospital Association. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010; 74 Suppl 1: S20-2. PMID: 20979958
15. Zuo L, Wang M, Beijing Hemodialysis Quality Control and Improvement Center. Current status of hemodialysis treatment in Beijing, China. Ethn Dis 2006; 16 (2 Suppl 2): S2-31-4. PMID: 16774007
16. Zuo L, Wang M, Beijing Hemodialysis Quality Control and Improvement Center. Current status of maintenance hemodialysis in Beijing, China. Kidney Int Suppl (2011)2013; 3: 167-169.
17. Gan L, Zuo L. Current ESRD burden and its future trend in Beijing, China. Clin Nephrol 2015; 83 (7 Suppl 1): 17-20. PMID: 25725236
18. Yao Q, Zhang W, Qian J. Dialysis status in China: a report from the Shanghai Dialysis Registry (2000-2005). Ethn Dis 2009; 19 (1 Suppl 1): S1-23-6. PMID: 19484870
19. Zhang W, Qian J. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purif 2012; 11: 233-236.
20. Yip WC-M, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China's huge and complex health-care reforms. Lancet 2012; 379: 833-4 doi: 10.1016/S0140-6736(11)61880-1 PMID: 22386036